GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and ...

Higher ultraprocessed food (UPF) intake is associated with an increased risk for early-onset colorectal conventional adenomas ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

A new study may shed light on why colon cancer is rising in younger adults — and it points to what many of us are ...

Using detailed imaging, genetic sequencing and bacterial culturing, researchers unveiled the first evidence of bacteria found ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

Ultra-processed items include boxed soups, frozen meals and products with long shelf lives — foods many Americans grew up eating in the 1970s, 80s and 90s.

A new study suggests that eating large amounts of ultra-processed foods may increase the risk of developing precancerous ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...